BioCentury
ARTICLE | Top Story

Amgen, Transkaryotic closing arguments

September 8, 2000 7:00 AM UTC

As expected, closing arguments were heard from representatives of AMGN and TKTX in their patent infringement suit related to TKTX's gene activated erythropoietin before Judge William Young of the U.S....